Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors

Yonghui Wang(Siemens (Hungary)), Xichen Lin(GlaxoSmithKline (China)), Yafei Huang(Huazhong University of Science and Technology), Yan Xu(Hebei Agricultural University), Qianqian Wu(Jiangsu University), Yaobang Cheng(GlaxoSmithKline (China)), Qinghua Meng(GlaxoSmithKline (China)), Ziqiang Cheng(Sichuan University), Qian Liu(Wuhan University), Wei Cai(GlaxoSmithKline (China)), Ling Zhou(Chinese PLA General Hospital), Fangbin Han(GlaxoSmithKline (China)), Feng Ren(Unknown), Guifeng Zhang(GlaxoSmithKline (China)), John D. Elliott(GlaxoSmithKline (China)), Stewart Leung(GlaxoSmithKline (China)), Zhijun Xiang(GlaxoSmithKline (China)), Sijie Lu(GlaxoSmithKline (China)), Jia‐Ning Xiang(GlaxoSmithKline (China)), Ting Yang(GlaxoSmithKline (China)), Yonggang Zhao(GlaxoSmithKline (China))
ACS Medicinal Chemistry Letters
May 26, 2015
Cited by 76


Related Papers